111 related articles for article (PubMed ID: 26347996)
1. Influence of verapamil on pharmacokinetics of pristimerin in rats.
Gao X; Zhang Y; Wang Y; Zhang Y; Wang Y; Liu S; Gao X
Biomed Chromatogr; 2016 Jun; 30(6):802-9. PubMed ID: 26347996
[TBL] [Abstract][Full Text] [Related]
2. Absorption and metabolism characteristics of pristimerin as determined by a sensitive and reliable LC-MS/MS method.
Dong C; Xu C; Liu H; Xu S; Gao Y; Peng J
Fitoterapia; 2015 Oct; 106():62-7. PubMed ID: 26299424
[TBL] [Abstract][Full Text] [Related]
3. Effects of Glycyrrhizic Acid on the Pharmacokinetics of Pristimerin in Rats and its Potential Mechanism.
Zhao X; Wu Y; Wang D
Eur J Drug Metab Pharmacokinet; 2018 Feb; 43(1):63-68. PubMed ID: 28631076
[TBL] [Abstract][Full Text] [Related]
4. The drug-drug interaction of sorafenib mediated by P-glycoprotein and CYP3A4.
Wang X; Zhang X; Huang X; Li Y; Wu M; Liu J
Xenobiotica; 2016 Jul; 46(7):651-658. PubMed ID: 26582036
[TBL] [Abstract][Full Text] [Related]
5. Influence of verapamil on the pharmacokinetics of rotundic acid in rats and its potential mechanism.
Shang H; Wang Z; Ma H; Sun Y; Ci X; Gu Y; Liu C; Si D
Pharm Biol; 2021 Dec; 59(1):200-208. PubMed ID: 33595422
[TBL] [Abstract][Full Text] [Related]
6. The effects of verapamil on the pharmacokinetics of curculigoside in rats.
Wang K; Zhao J; Lang J
Pharm Biol; 2016 Dec; 54(12):3001-3008. PubMed ID: 27328778
[TBL] [Abstract][Full Text] [Related]
7. Effect of Verapamil, a P-glycoprotein-1 and Cytochrome P450 3A4 Inhibitor, on Pharmacokinetics and Metabolic Stability of Ripretinib: A Drug-Drug Interaction Study in Rats.
Mudavath S; Ashok D
Eur J Drug Metab Pharmacokinet; 2023 Nov; 48(6):733-746. PubMed ID: 37831396
[TBL] [Abstract][Full Text] [Related]
8. Effects of verapamil on the pharmacokinetics of dihydromyricetin in rats and its potential mechanism.
Huang Y; Zhao J; Jian W; Wang G
Xenobiotica; 2018 Aug; 48(8):839-844. PubMed ID: 28795912
[TBL] [Abstract][Full Text] [Related]
9. Effects of verapamil on the pharmacokinetics of puerarin in rats.
Zhou Y; Song X; Dong G
Xenobiotica; 2019 Oct; 49(10):1178-1182. PubMed ID: 30173622
[TBL] [Abstract][Full Text] [Related]
10. Influence of Verapamil on Pharmacokinetics of Triptolide in Rats.
Zhang Y; Li J; Lei X; Zhang T; Liu G; Yang M; Liu M
Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):449-56. PubMed ID: 25854676
[TBL] [Abstract][Full Text] [Related]
11. Investigation of the influence of glycyrrhizin on the pharmacokinetics of celastrol in rats using LC-MS and its potential mechanism.
Yan G; Zhang H; Wang W; Li Y; Mao C; Fang M; Yi X; Zhang J
Xenobiotica; 2017 Jul; 47(7):607-613. PubMed ID: 27919190
[TBL] [Abstract][Full Text] [Related]
12. Effect of verapamil on the pharmacokinetics of hydroxycamptothecin and its potential mechanism.
Xing H; Luo X; Li Y; Fan C; Liu N; Cui C; Li W
Pharm Biol; 2020 Dec; 58(1):152-156. PubMed ID: 31990625
[No Abstract] [Full Text] [Related]
13. Absorption and Metabolism Characteristics of Triptolide as Determined by a Sensitive and Reliable LC-MS/MS Method.
Gong X; Chen Y; Wu Y
Molecules; 2015 May; 20(5):8928-40. PubMed ID: 25993421
[TBL] [Abstract][Full Text] [Related]
14. Influence of verapamil on the pharmacokinetics of oridonin in rats.
Liu J; Zhang N; Li N; Fan X; Li Y
Pharm Biol; 2019 Dec; 57(1):787-791. PubMed ID: 31747844
[No Abstract] [Full Text] [Related]
15. P-glycoprotein is responsible for the poor intestinal absorption and low toxicity of oral aconitine: in vitro, in situ, in vivo and in silico studies.
Yang C; Zhang T; Li Z; Xu L; Liu F; Ruan J; Liu K; Zhang Z
Toxicol Appl Pharmacol; 2013 Dec; 273(3):561-8. PubMed ID: 24120885
[TBL] [Abstract][Full Text] [Related]
16. Effects of glycyrrhizin on the pharmacokinetics of puerarin in rats.
Zhao Q; Wang Y; Wang H; Feng L
Xenobiotica; 2018 Nov; 48(11):1157-1163. PubMed ID: 29099639
[TBL] [Abstract][Full Text] [Related]
17. Effect of P-glycoprotein inhibitor, verapamil, on oral bioavailability and pharmacokinetics of irinotecan in rats.
Bansal T; Mishra G; Jaggi M; Khar RK; Talegaonkar S
Eur J Pharm Sci; 2009 Mar; 36(4-5):580-90. PubMed ID: 19135530
[TBL] [Abstract][Full Text] [Related]
18. In vitro to in vivo evidence of the inhibitor characteristics of Schisandra lignans toward P-glycoprotein.
Liang Y; Zhou Y; Zhang J; Liu Y; Guan T; Wang Y; Xing L; Rao T; Zhou L; Hao K; Xie L; Wang GJ
Phytomedicine; 2013 Aug; 20(11):1030-8. PubMed ID: 23731657
[TBL] [Abstract][Full Text] [Related]
19. Drug-drug interactions between moxifloxacin and rifampicin based on pharmacokinetics in vivo in rats.
Huang L; Liu J; Yu X; Shi L; Liu J; Xiao H; Huang Y
Biomed Chromatogr; 2016 Oct; 30(10):1591-8. PubMed ID: 27028459
[TBL] [Abstract][Full Text] [Related]
20. Verapamil and pristimerin pharmacokinetic drug-drug interaction study in rats - perspectives.
Srinivas NR
Biomed Chromatogr; 2016 Dec; 30(12):2074. PubMed ID: 27444812
[No Abstract] [Full Text] [Related]
[Next] [New Search]
